Policy
All members of the UK HealthCare
Medical Staff shall follow the established guidelines set forth in this policy
in determining death.
Procedure
Ordinary Circumstances
In ordinary circumstances, the
signs of death are:
1.
Unresponsiveness of the limbs and
face to deep pressure and painful stimuli applied to all four extremities and
over the temporomandibular joint and the supraorbital ridge;
2.
Absence of pulse and heartbeat
for a minimum of five minutes;
3.
Absence of spontaneous
respiratory movement and all other movement; and
4.
Absence of brain stem reflexes.
Brain Death (Death by Neurologic Criteria)
Brain death is defined as the
irreversible cessation of all brain and brain stem functions. Under Kentucky law, death is deemed to occur when these
requirements of brain death are met. See KRS 397.1005. Brain death has been recently referred
to as death by neurologic criteria.
In the absence of gross anatomic brain damage, neuroimaging shall be
performed to explain the cause of the patient’s coma.
Certification of brain death or death by neurologic criteria in adult patients
shall be attested to and documented by two physicians who have expertise in the
clinical determination of brain death, at least one being a member of the
active medical staff (attending).
The second physician may be a properly trained member of the medical
staff or a licensed physician in his/her 3rd or higher post-graduate
year of training in neurology, neurosurgery, emergency medicine, anesthesiology
or general surgery or in his/her 1st
or higher year of training in a cardiology or pulmonary fellowship. Certification of brain death or death
by neurologic criteria in connection with a pediatric patient (< 15 years
old) shall be attested to and documented by two attending physicians who have expertise
in the clinical determination of brain death.
Diagnosis of Death by Neurologic Criteria
The following prerequsites shall
be present when diagnosing death by neurologic criteria:
1. An irreversible and proximate cause of the presumed
brain death shall have been established. This should be supported by
neuroimaging (MRI or CT scan studies),
or gross anatomical brain damage by physical examination or craniotomy as
assessed by a qualified physician, that indicate that the brain is irreparably
damaged, extruded, divided, or destroyed.
2. The patient should be observed for at least four (4)
hours following the onset of the brain insult to minimize
the possibility of recovery.
3. In cases of anoxic brain death, in which no significant structural change is evident on
radiography, a 24 hour period of
observation and repeat clinical examination are required. This interval can be shortened to one
hour if a nuclear perfusion scan or cerebral angiogram demonstrate absence of circulation to the entire brain.
4.
In patients who have
been resuscitated [“return of circulation” (ROC)] by CPR for cardiopulmonary arrest (followed with or without
therapeutic hypothermia), the determination of death by
neurologic criteria shall be deferred for 24 hours after returning to
normothermia in both adult and pediatric patients, unless absence of brain
blood flow is demonstrated by by ancillary testing.
5. Temperature ≥36oC [≥35oC
in children (<15 years)], systemic arterial systolic blood pressure ≥ 100 mm
Hg or in children not less than 2 standard
deviations below age appropriate norm.
6. Confounding factors that could mimic “brain death” have
been ruled out. Clinical criteria alone may not be used to establish brain
death in the presence of: neuromuscular blockade, shock/severe hypotension,
significant levels of sedatives and central nervous system depressants in the
patient's serum (e.g., barbiturates, benzodiazepines), severe metabolic
disturbance (e.g., hyperosmolar coma, hepatic encephalopathy), severe
electrolytes disturbances (glucose < 70 or > 300; Sodium < 110 or >
160; Calcium >12) or acid-base imbalance (pH < 7.20). Demonstration of absent brain blood flow on ancillary
testing can confirm brain death in the presence of central nervous system
depressants if the remainder of the clinical examination supports the diagnosis
of brain death.
In addition, currently acceptable
clinical criteria for determination of death by neurologic criteria in the
presence of cardiac activity and relatively normal blood pressure, whether or
not artificial means are used to maintain the circulation of oxygenated blood, require
all of the following:
1.Cerebral unconsciousness and
motor unresponsiveness to stimuli which are normally intensely painful (i.e.,
GCS or EMV of 3). True decerebrate
or decorticate posturing or seizures are inconsistent with the diagnosis of brain
death.
2.Absence of spontaneous movements for an observation period of at
least one hour, except for spinal reflex activity. Clinical judgment shall be exercised to determine the
appropriate observation period based on the circumstances and condition of the
individual patient.
3.Absence of reflexes which involve cranial nerves, which includes
the following:
a. The pupils must be fixed at midpoint or larger in diameter and
nonreactive to sharp changes in the intensity of incipient light.
b. No ocular responses or eye movements to head turning or
irrigation of ear with ice water.
c.Absence of corneal reflexes.
d..No gag, cough, or retching reflex in response to pharyngeal or
tracheal stimulation with suction catheter.
4. Apnea. No respiratory movements after the patient is disconnected
from the mechanical ventilator and the arterial carbon dioxide level has risen
to sufficient level. See box below for detail on
performance of apnea study.After meeting all of the above criteria for brain
death, demonstration of apnea is the final and essential component of the
clinical determination of brain death.
Adequate
testing for apnea is very important.
An accepted method is:
1.
Ventilation
with 100% oxygen and 5 cm PEEP at an appropriate rate (for normal PaCO2) for a
10-minute period
2.
Thereafter,
obtain a baseline arterial blood gas.
PaO2 should be > 200, and PaCO2 should be between 35 and 45 without
acidosis.
3.
Thereafter,
place on a t-piece with 5-10 cm of CPAP and an oxygen flow of 12 L/min.
4.
Observe
abdomen and chest for any respiratory activity for 8-10 minutes.
5. Obtain an arterial blood gas at the
termination of the apnea test, then resume ventilation.
Testing of arterial blood gases shall be used to confirm that the PaCO2
is above 60 or 20 mm above the patient’s usual baseline PaCO2. Any spontaneous breathing efforts
indicate that part of the brainstem is functioning and that the patient is not
brain dead.
If the systolic pressure falls below 90 mm Hg
or the SpO2 falls below 85% the test shall be aborted. Unless an appropriate rise in PaCO2 has
already occurred, the test shall be considered uninterpretable and an ancillary
test shall be performed.
Caution
should be used in interpreting apnea in patients with high levels of
central nervous system depressant drugs, severe neuromuscular disease, high
spinal cord injury, or severe COPD with a reduced carbon dioxide drive (carbon
dioxide retainers) (“confounding factors”.). If there is doubt, consider performing an ancillary test. Only one apnea test is required in
adults which may be done at the time of either clinical examination. Two apnea
tests are required in children, one with each clinical examination.
The above four (4) conditions (clinical
criteria for determination of death by neurologic criteria-unconsciousness,
absence of movement, absence of reflexes, apnea) must persist unchanged for at least
one (1) hour in adults, for 24 hours in full term infants under 31 days of age
, and for 12 hours in children 31 days to 14 years of age.
Ancillary Testing to
assist with the Determination of Brain Death
An ancillary test is recommended
to assist with determination of brain death when the preceding clinical
exam (including apnea test) cannot be adequately assessed and documented.
If any part of the full brain
death exam or apnea test cannot be adequately performed or is not tolerated, it
shall be documented in the medical record and an ancillary test shall be
utilized to support the diagnosis.
Ancillary testing is not a
substitute for performing a clinical examination as completely as is possible.
Ancillary testing shall only be performed if
the clinical examination is consistent with death by neurologic criteria (“brain
death”). Brain death shall not be
determined based on an ancillary test if the clinical examination is not
compatible with brain death.
Prior to performing ancillary testing, the following prerequisites must be present:
1.
An irreversible and proximate
cause of brain death has been established
2.
The patients temperature is ≥36oC
[≥35oC in children (<15 years)]
3. The patient’s systemic blood pressure is ≥100 systolic or MAP is ≥
60 mm Hg or in children systolic
BP is not less than 2 standard deviations below age appropriate norm.
4.
The patient has a Glasgow Coma Score
(GCS)/EMV of 3.
5.
The patient meets all of the
clinical criteria for brain death (listed above) as can be assessed.
The following are indications that ancillary testing should be
performed to assist with determination of brain death.
1.
Portions of the complete clinical examination for brain death cannot be done.
2.
Presence of residual movement or
spinal reflexes that are the subject of differing interpretation by clinicians
performing the examination.
3.
Apnea test could not be interpreted
because of high levels of central nervous system depressant drugs, severe
neuromuscular disease or high cervical spine injury or possible chronic carbon
dioxide retention (“confounding factors”.)
4.
Apnea test could not be completed
because patient developed severe (as defined above) hypoxemia or hypotension
5.
Presence of high dose
hypnotic/narcotic drugs (e.g., pentobarbital >10 mcg/mL)
6.
Post cardiac arrest with or
without therapeutic hypothermia.
7.
Physician or family discomfort/doubt with the results of the clinical
determination
When
ancillary testing is indicated, the preferred tests to confirm brain death are:
1.
a.Cerebral
scintigraphy (nuclear cerebral blood flow scanning) demonstrating no
evidence of brain perfusion following the SNM Practice Guidline for Brain Death
Scintigraphy 2.0 (Donohoe 2012)
b.Catheter
four vessel cerebral angiography with contrast demonstrating absence of circulation
to the entire brain.
If the preferred tests cannot be
performed, the following is an acceptable test to confirm brain death:
1.
Transcranial Doppler (TCD) demonstrating cerebral circulatory arrest (CCA) in both middle
cerebral arteries and the basilic artery as manifested by either oscillating (“reverberating”)
flow, or short systolic spikes.
The
following test is considered unreliable and thus not recommended to confirm
brain death: